Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in non-Hodgkin's lymphoma

Joseph A. Sparano, Abdissa Negassa, Erick Lansigan, Robin Locke, Chamath R. De Silva, Peter H. Wiernik

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint Dive into the research topics of 'Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences